Avid Bioservices Inc (CDMO)

[biopharm]

Hakan Mellstedt : Peregrine Pharmaceuticals KOL :

Hakan is one KOL that I keep trying to figure out what his role will be...

not sure if this is new but definitely don't remember seeing this before, as scientific advisor of Korea Stem Cell Bank as it just popped up today on a google search... so its possible?? they just updated his profile on this link below.

Dr. Hakan Mellstedt, MD, PhD serves as Scientific Advisor of Korea Stem Cell Bank Co., Ltd. Dr. Mellstedt is a Professor of Oncologic Biotherapy at the Karolinska Institute and Managing Director of Cancer Center Karolinska, Karolinska Institute, Stockholm, Sweden. He serves as Chief Physician at the Department of Oncology & Haematology, Karolinska Hospital, Stockholm, and has specialist certificates in Oncology, Hematology and Internal Medicine. He served as a Scientific Advisor of Micromet, Inc. (also known as Micromet Ag). Dr. Mellstedt served as Head of the Division of Experimental Oncology, Uppsala University from 1996 to 1999. He was Editor-in-Chief, Review Series ONCOLOGY since 1996, and served on the editor board of many important journals related to the cancer field. He serves as Chairman and Member of clinical trial advisory board of Oxigene Inc. He served as Chairman, Swedish Society of Oncology from 1993 to 1999. Dr. Mellstedt serves as a Member of Medical Advisory Board at KAEL-GemVax Co., Ltd. Dr. Mellstedt serves as a Member of Advisory Board of Gemvax As. Dr. Mellstedt serves Chairman and President of ESMO (European Society for Medical Oncology). He serves as a Director of Kancera AB. He served as a Member of the Medical Advisory Board at Wilex AG. He served as a Member of Scientific Advisory Board of Affibody Holding AB (also known as Affibody AB). He published more than 450 articles in the areas of hematology, Contributions to Biomolecular Technologies. His Scientific prizes are : Alfaferone 1989 Prize(Italian Institute of Immunology) and Jan Waldenström Award , VIIIth International Myeloma Workshop, 2001. Dr. Mellstedt received M.D and Ph.D at Karolinska Institute, Stockholm, Sweden.

http://investing.businessweek.com/research/stocks/private/person.asp?personId=21875542&privcapId=47790443&previousCapId=117152678&previousTitle=KANCERA%20AB

----------------------------------------------------------

Hakan
Mellstedt

Scientific
Advisor

- Professor of Oncologic Biotherapy at the Karolinska Institute
- Managing Director of CancerCentreKarolinska (CCK) at the Karolinska University Hospital in Stockholm, Sweden
- Chief Physician in the Departments of Oncology and Haematology
- Chairman of the Swedish Society of Oncology
- Chairman of the ESMO Foundation
- Past President of ESMO
- President of ESMO
- M.D/Ph.D at Karolinska Institute, Stockholm, Sweden

http://kscb.co.kr/cell/eng/company/company4.php?PHPSESSID=e97f422a2166c2648c1ccb5aa3fe0e62